Loading company…
Melbourne clinical trial organization running early-phase Phase 1 studies for pharmaceutical and biotech companies worldwide.
Founded in 1993 and headquartered in Melbourne, Australia, Nucleus Network, LLC conducts early-stage clinical trials, mainly Phase 1 studies, for pharmaceutical and biotech clients. Its studies range from two days to several weeks and involve healthy volunteers or patients. Blackstone Group acquired the company from Crescent Capital Partners in October 2021, and in the most recent year it reported revenue of USD 34.10 mn and EBITDA of USD 8.90 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in